Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Naranjo Scale"'
Autor:
Shima Heidari, Mahsa Panahishokouh, Davoud Babakhani, Sohrab Aghabeigi, Mohammad Vaezi, Shahideh Amini, Molouk Hadjibabaie, Bita Shahrami
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 363-371 (2023)
Vincristine (VCR) as a key drug for the treatment of acute lymphoblastic leukemia (ALL) is associated with neurotoxicity. We present a young man with a history of controlled childhood seizures who was diagnosed with pre-B-cell ALL and developed gener
Externí odkaz:
https://doaj.org/article/fed4a49a08b544b0a3f8929263c52b19
Autor:
Kiran Dhonju, Ashmita Gautam, Abhinav Dahal, Niraj Kumar Sharma, Divas Adhikari, Lina Devkota, Prabhat Adhikari, Sampurna Tuladhar, Bishnu Deep Pathak, Sabin Banmala
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message Dolutegravir, the most recent antiretroviral drug with high efficacy, good tolerability, infrequent drug–drug interactions, and a favorable safety profile has not been reported in current literature as a cause of acquired sider
Externí odkaz:
https://doaj.org/article/34e9fc93f93e41d4bda484d922e92aa5
Autor:
Haya M. Almalag, Shiekha S. Alaujan, Hawazin S. Alhazzani, Lamia A. Alzamel, Reem S. Tashkandi, Hussain F. Alarfaj, Abdurhman S. Alarfaj, Mohammed A. Omair
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 7, Pp 1044-1051 (2022)
Background: Few Saudi studies have examined adverse drug reactions (ADRs) in patients with rheumatoid arthritis (RA) receiving intravenous (IV) originator biologics. Therefore, this study aimed to evaluate the prevalence, types, and predictors of ADR
Externí odkaz:
https://doaj.org/article/1dff7dba12d44c1b8e53de5f44b45c59
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 6, Pp 735-741 (2022)
Purpose: This study aimed to assess the type, severity, seriousness, reasons, and outcomes of adverse drug reactions (ADRs) in the reports submitted to the regional spontaneous ADR database. Methods: A retrospective observational study was conducted
Externí odkaz:
https://doaj.org/article/b6cffe8367984fdabc8eb66b959a67c5
Publikováno v:
International Journal of General Medicine, Vol Volume 14, Pp 7819-7823 (2021)
Majed Al Jeraisy,1,2 Shaden Al Osaimi,1 Abdullah Al Hawas,1 Alanoud Muamar,1 Lamia Aleidi,3 Njoud Khonain,4 Mostafa A Abolfotouh2 1College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs,
Externí odkaz:
https://doaj.org/article/76151f521a734912aee00dbbe632f59c
Autor:
Bishal Dhakal, Sagun Dawadi, Laxman Khadka, Sujan Bohara, Shashank Neupane, Priajan Ale Magar, Bishnu Deep Pathak, Binit Upadhaya Regmi
Publikováno v:
Clinical Case Reports, Vol 10, Iss 12, Pp n/a-n/a (2022)
Abstract Ciprofloxacin, among the many Fluoroquinolones, has been widely used as a broad‐spectrum antibiotic due to its wide range of action and relatively safe adverse effect profile. However, among the cutaneous adverse drug reactions due to Cipr
Externí odkaz:
https://doaj.org/article/7241d8db815240a3a25f5472191a866b
Autor:
Nori J. L. Smeets, Ruud J. R. Eijk, Saskia N. de Wildt, Charlotte M. H. H. T. Bootsma-Robroeks
Publikováno v:
BMC Pediatrics, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Alemtuzumab is a T cell depleting antibody agent used as induction immunosuppressant therapy in solid organ transplant recipients. In addition, it is being increasingly used to treat severe or glucocorticoid-resistant graft reject
Externí odkaz:
https://doaj.org/article/8618f3b5bdda44f28bed52a5a52d5e77
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.